BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38230274)

  • 1. Bruceine B Displays Potent Antimyeloma Activity by Inducing the Degradation of the Transcription Factor c-Maf.
    Li H; Zhu X; Sun Z; Wang Q; Song S; Xu Y; He G; Mao X
    ACS Pharmacol Transl Sci; 2024 Jan; 7(1):176-185. PubMed ID: 38230274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-bacterial and anti-viral nanchangmycin displays anti-myeloma activity by targeting Otub1 and c-Maf.
    Xu Y; Sun T; Zeng K; Xu M; Chen J; Xu X; Zhang Z; Cao B; Tang X; Wu D; Kong Y; Zeng Y; Mao X
    Cell Death Dis; 2020 Sep; 11(9):818. PubMed ID: 32999280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mebendazole elicits potent antimyeloma activity by inhibiting the USP5/c-Maf axis.
    Chen XH; Xu YJ; Wang XG; Lin P; Cao BY; Zeng YY; Wang Q; Zhang ZB; Mao XL; Zhang T
    Acta Pharmacol Sin; 2019 Dec; 40(12):1568-1577. PubMed ID: 31197245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the Otub1/c-Maf axis by the herbal acevaltrate induces myeloma cell apoptosis.
    Sun T; Xu Y; Xu Z; Cao B; Zhang Z; Wang Q; Kong Y; Mao X
    Cell Commun Signal; 2021 Feb; 19(1):24. PubMed ID: 33627137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma.
    Xu Y; Xu M; Tong J; Tang X; Chen J; Chen X; Zhang Z; Cao B; Stewart AK; Moran MF; Wu D; Mao X
    Blood; 2021 Mar; 137(11):1478-1490. PubMed ID: 32842143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis.
    Xu Y; Zhang Z; Li J; Tong J; Cao B; Taylor P; Tang X; Wu D; Moran MF; Zeng Y; Mao X
    J Hematol Oncol; 2017 Jul; 10(1):132. PubMed ID: 28673317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the oncogenic transcription factor c-Maf for the treatment of multiple myeloma.
    Jiang Q; Mao H; He G; Mao X
    Cancer Lett; 2022 Sep; 543():215791. PubMed ID: 35700821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis.
    Wang S; Juan J; Zhang Z; Du Y; Xu Y; Tong J; Cao B; Moran MF; Zeng Y; Mao X
    Cell Death Dis; 2017 Sep; 8(9):e3058. PubMed ID: 28933784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of small compounds that inhibit multiple myeloma proliferation by targeting c-Maf transcriptional activity.
    Asano K; Kikuchi K; Takehara M; Ogasawara M; Yoshioka Y; Ohnishi K; Iwata A; Shimizu S; Tanaka M
    Biochem Biophys Res Commun; 2023 Dec; 684():149135. PubMed ID: 37879249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transmembrane protein TMEPAI induces myeloma cell apoptosis by promoting degradation of the c-Maf transcription factor.
    Du Y; Liu Y; Xu Y; Juan J; Zhang Z; Xu Z; Cao B; Wang Q; Zeng Y; Mao X
    J Biol Chem; 2018 Apr; 293(16):5847-5859. PubMed ID: 29467225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ubiquitin ligase HERC4 suppresses MafA transcriptional activity triggered by GSK3β in myeloma by atypical K63-linked polyubiquitination.
    Zhang Z; Li M; Lin P; Ren Y; He Y; Wang S; Xu Y; Cao B; Wang G; Moran MF; Mao X
    J Biol Chem; 2023 May; 299(5):104675. PubMed ID: 37028761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.
    He Y; Wang S; Tong J; Jiang S; Yang Y; Zhang Z; Xu Y; Zeng Y; Cao B; Moran MF; Mao X
    J Biol Chem; 2020 Feb; 295(7):2084-2096. PubMed ID: 31822558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of spinal muscular atrophy via correction of the SMN2 splicing defect by Brucea javanica (L.) Merr. extract and Bruceine D.
    Baek J; Jeong H; Ham Y; Jo YH; Choi M; Kang M; Son B; Choi S; Ryu HW; Kim J; Shen H; Sydara K; Lee SW; Kim SY; Han SB; Oh SR; Cho S
    Phytomedicine; 2019 Dec; 65():153089. PubMed ID: 31563042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice.
    Zhang Z; Tong J; Tang X; Juan J; Cao B; Hurren R; Chen G; Taylor P; Xu X; Shi CX; Du J; Hou J; Wang G; Wu D; Stewart AK; Schimmer AD; Moran MF; Mao X
    Blood; 2016 Mar; 127(13):1676-86. PubMed ID: 26825710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antitrypanosomal activities of quassinoid compounds from the fruits of a medicinal plant, Brucea javanica.
    Bawm S; Matsuura H; Elkhateeb A; Nabeta K; Subeki ; Nonaka N; Oku Y; Katakura K
    Vet Parasitol; 2008 Dec; 158(4):288-94. PubMed ID: 18986767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin.
    Mao X; Stewart AK; Hurren R; Datti A; Zhu X; Zhu Y; Shi C; Lee K; Tiedemann R; Eberhard Y; Trudel S; Liang S; Corey SJ; Gillis LC; Barber DL; Wrana JL; Ezzat S; Schimmer AD
    Blood; 2007 Dec; 110(12):4047-54. PubMed ID: 17875808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of efficacy of bruceine A, a natural quassinoid compound extracted from a medicinal plant, Brucea javanica, for canine babesiosis.
    Nakao R; Mizukami C; Kawamura Y; Subeki ; Bawm S; Yamasaki M; Maede Y; Matsuura H; Nabeta K; Nonaka N; Oku Y; Katakura K
    J Vet Med Sci; 2009 Jan; 71(1):33-41. PubMed ID: 19194074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bruceine D Isolated from Brucea Javanica (L.) Merr. as a Systemic Feeding Deterrent for Three Major Lepidopteran Pests.
    Mao G; Tian Y; Sun Z; Ou J; Xu H
    J Agric Food Chem; 2019 Apr; 67(15):4232-4239. PubMed ID: 30901209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bruceine D induces apoptosis in human chronic myeloid leukemia K562 cells via mitochondrial pathway.
    Zhang JY; Lin MT; Tung HY; Tang SL; Yi T; Zhang YZ; Tang YN; Zhao ZZ; Chen HB
    Am J Cancer Res; 2016; 6(4):819-26. PubMed ID: 27186433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression.
    Annunziata CM; Hernandez L; Davis RE; Zingone A; Lamy L; Lam LT; Hurt EM; Shaffer AL; Kuehl WM; Staudt LM
    Blood; 2011 Feb; 117(8):2396-404. PubMed ID: 21163924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.